Share on StockTwits

Thermo Fisher Scientific (NYSE:TMO) SVP Thomas W. Loewald sold 2,349 shares of the stock on the open market in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $120.90, for a total value of $283,994.10. Following the completion of the transaction, the senior vice president now directly owns 36,862 shares of the company’s stock, valued at approximately $4,456,616. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

TMO has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus initiated coverage on shares of Thermo Fisher Scientific in a research note on Monday, August 11th. They set a “buy” rating and a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 7th. They now have a $126.00 price target on the stock. Finally, analysts at Macquarie reiterated an “outperform” rating on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. They now have a $135.00 price target on the stock, up previously from $130.00. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $134.69.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down 0.01% during mid-day trading on Thursday, hitting $120.07. 1,250,386 shares of the company’s stock traded hands. Thermo Fisher Scientific has a one year low of $88.44 and a one year high of $127.63. The stock has a 50-day moving average of $121.1 and a 200-day moving average of $119.9. The company has a market cap of $47.950 billion and a P/E ratio of 31.21.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, July 23rd. The company reported $1.72 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.62 by $0.10. The company had revenue of $4.32 billion for the quarter, compared to the consensus estimate of $4.25 billion. During the same quarter last year, the company posted $1.32 earnings per share. Thermo Fisher Scientific’s revenue was up 33.4% compared to the same quarter last year. On average, analysts predict that Thermo Fisher Scientific will post $6.94 earnings per share for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.